Today, Relay Therapeutics Inc Inc’s (NASDAQ: RLAY) stock fell $0.49, accounting for a 1.46% decrease. Relay opened at $32.10 before trading between $33.29 and $31.09 throughout Friday’s session. The activity saw Relay’s market cap fall to $3,051,389,351 on 1,822,483 shares -above their 30-day average of 372,265.
About Relay Therapeutics Inc
Relay Therapeutics, Inc. operates as a biotechnology company. The Company develops durgs for the treatment of cancer. Relay Therapeutics serves customers in the United States.